FindTrial
Sign In

Effect on blood glucose level in pregnant women after receiving antenatal corticosteroid therapy given for fetal lung maturity in diabetic versus non-diabetic pregnant women

Comparison of effect of antenatal corticosteroid therapy (ACST)on glycemic status of diabetic versus non-diabetic pregnant women - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/069079
Enrollment
80
Registered
2024-06-18
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseases

Interventions

Intervention1: Antenatal corticosteroid therapy will be given for fetal lung maturity and will assess the changes in blood glucose level: After ACST ,the changes in glycemic status of diabetic versus

Sponsors

Pt BD Sharma pgims rohtak haryana
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All pregnant women receiveing ACST

Exclusion criteria

Exclusion criteria: Diabetic ketoacidosis Patient taking drugs which causes hyperglycemia

Design outcomes

Primary

MeasureTime frame
Blood sugar levels after ACST administrationTimepoint: Base line,DAY 1,DAY2,DAY3,DAY4,DAY5—

Secondary

MeasureTime frame
Change in management for control of blood glucose levelsTimepoint: Day1 to Day5—

Countries

India

Contacts

Public ContactSurbhi Kumari

Pt.B.D Sharma pgims rohtak haryana

surbhikri72095@gmail.com7250795916

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026